between 2021 and 2023, for example, GLP-1 RA prescriptions shot up by approximately 60%, the two most common brands being Ozempic and Wegovy
Three Months: 10-15% weight loss with diet and exercise
Store lyophilized Tirzepatide 30mg at -20C for long-term stability
This question arises as more patients use this GLP-1 receptor agonist for type 2 diabetes and weight management
There is also an ongoing cardiovascular outcomes trial of tirzepatide (SURPASS-CVOT) in individuals with type 2 diabetes and cardiovascular disease [91], which, if successful, will broaden the use of tirzepatide to those with manifest or increased risk for CVD, as is the case for GLP-1 receptor agonists [22]
Also fasting plasma glucose levels decreased significantly by 16.7% compared to baseline and by 18.4% compared to placebo